Many disease-associated variants of hTERT retain high telomerase enzymatic activity

Nucleic Acids Research

Volumn 41, Issue 19, 2013, Pages 8969-8978

  Zaug, Arthur J ^a   Crary, Sharon M ^a,b   Jesse Fioravanti, Matthew ^a   Campbell, Kristina ^a   Cech, Thomas R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DEPAUW UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RECONSTITUTION; GENE; GENE FREQUENCY; GENETIC VARIABILITY; HETEROZYGOSITY; HTERT GENE; HUMAN; HUMAN CELL; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PURIFICATION; RETICULOCYTE; RETROPOSON; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

CELL LINE; HUMANS; MUTATION; TELOMERASE; TELOMERE-BINDING PROTEINS;

EID: 84886035609     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt653     Document Type: Article

References (51)

1. Greider, C.W. and Blackburn, E.H. (1989) A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature, 337, 331-337.
2. Nakamura, T.M., Morin, G.B., Chapman, K.B., Weinrich, S.L., Andrews, W.H., Lingner, J., Harley, C.B. and Cech, T.R. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955-959.
3. Meyerson, M., Counter, C.M., Eaton, E.N., Ellisen, L.W., Steiner, P., Caddle, S.D., Ziaugra, L., Beijersbergen, R.L., Davidoff, M.J., Liu, Q. et al. (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90, 785-795.
4. Podlevsky, J.D. and Chen, J.J. (2012) It all comes together at the ends: telomerase structure, function, and biogenesis. Mutat. Res., 730, 3-11.
5. Nandakumar, J. and Cech, T.R. (2013) Finding the end: recruitment of telomerase to telomeres. Nat. Rev. Mol. Cell. Biol., 14, 69-82.
6. Strong, M.A., Vidal-Cardenas, S.L., Karim, B., Yu, H., Guo, N. and Greider, C.W. (2011) Phenotypes in mTERT(+)/(-) and mTERT(-)/(-) mice are due to short telomeres, not telomereindependent functions of telomerase reverse transcriptase. Mol. Cell. Biol., 31, 2369-2379.
7. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S. and Wright, W.E. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349-352.
8. Mitchell, J.R., Wood, E. and Collins, K. (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature, 402, 551-555.
9. Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P.J. and Dokal, I. (2001) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature, 413, 432-435.
10. Armanios, M., Chen, J.L., Chang, Y.P., Brodsky, R.A., Hawkins, A., Griffin, C.A., Eshleman, J.R., Cohen, A.R., Chakravarti, A., Hamosh, A. et al. (2005) Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA, 102, 15960-15964.
11. Savage, S.A., Giri, N., Baerlocher, G.M., Orr, N., Lansdorp, P.M. and Alter, B.P. (2008) TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am. J. Hum. Genet., 82, 501-509.
12. Ballew, B.J., Yeager, M., Jacobs, K., Giri, N., Boland, J., Burdett, L., Alter, B.P. and Savage, S.A. (2013) Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum. Genet., 132, 473-480.
13. Walne, A.J., Vulliamy, T., Kirwan, M., Plagnol, V. and Dokal, I. (2013) Constitutional mutations in RTEL1 cause severe dyskeratosis congenita. Am. J. Hum. Genet., 92, 448-453.
14. Trudeau, M.A. and Wong, J.M. (2010) Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Curr. Pharmacogenomics Person. Med., 8, 7-24.
15. Artandi, S.E., Chang, S., Lee, S.L., Alson, S., Gottlieb, G.J., Chin, L. and DePinho, R.A. (2000) Telomere dysfunction promotes nonreciprocal translocations and epithelial cancers in mice. Nature, 406, 641-645.
16. De Lange, T. (2005) Telomere-related genome instability in cancer. Cold Spring Harb. Symp. Quant. Biol., 70, 197-204.
17. Alter, B.P., Giri, N., Savage, S.A. and Rosenberg, P.S. (2009) Cancer in dyskeratosis congenita. Blood, 113, 6549-6557.
18. Calado, R.T., Regal, J.A., Hills, M., Yewdell, W.T., Dalmazzo, L.F., Zago, M.A., Lansdorp, P.M., Hogge, D., Chanock, S.J., Estey, E.H. et al. (2009) Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc. Natl Acad. Sci. USA, 106, 1187-1192.
19. Yamaguchi, H., Calado, R.T., Ly, H., Kajigaya, S., Baerlocher, G.M., Chanock, S.J., Lansdorp, P.M. and Young, N.S. (2005) Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med., 352, 1413-1424.
20. Mozdy, A.D. and Cech, T.R. (2006) Low abundance of telomerase in yeast: implications for telomerase haploinsufficiency. RNA, 12, 1721-1737.
21. De Cian, A., Cristofari, G., Reichenbach, P., De Lemos, E., Monchaud, D., Teulade-Fichou, M.P., Shin-Ya, K., Lacroix, L., Lingner, J. and Mergny, J.L. (2007) Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action. Proc. Natl Acad. Sci. USA, 104, 17347-17352.
22. Wang, F., Podell, E.R., Zaug, A.J., Yang, Y., Baciu, P., Cech, T.R. and Lei, M. (2007) The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature, 445, 506-510.
23. Zhao, Y., Sfeir, A.J., Zou, Y., Buseman, C.M., Chow, T.T., Shay, J.W. and Wright, W.E. (2009) Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell, 138, 463-475.
24. Zaug, A.J., Podell, E.R., Nandakumar, J. and Cech, T.R. (2010) Functional interaction between telomere protein TPP1 and telomerase. Genes Dev., 24, 613-622.
25. Zheng, L., Baumann, U. and Reymond, J.L. (2004) An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res., 32, e115.
26. Cristofari, G. and Lingner, J. (2006) Telomere length homeostasis requires that telomerase levels are limiting. EMBO J., 25, 565-574.
27. Lei, M., Podell, E.R. and Cech, T.R. (2004) Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat. Struct. Mol. Biol., 11, 1223-1229.
28. Latrick, C.M. and Cech, T.R. (2010) POT1-TPP1 enhances telomerase processivity by slowing primer dissociation and aiding translocation. EMBO J., 29, 924-933.
29. Nandakumar, J., Bell, C.F., Weidenfeld, I., Zaug, A.J., Leinwand, L.A. and Cech, T.R. (2012) The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature, 492, 285-289.
30. Alder, J.K., Chen, J.J., Lancaster, L., Danoff, S., Su, S.C., Cogan, J.D., Vulto, I., Xie, M., Qi, X., Tuder, R.M. et al. (2008) Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl Acad. Sci. USA, 105, 13051-13056.
31. Xie, M., Podlevsky, J.D., Qi, X., Bley, C.J. and Chen, J.J. (2010) A novel motif in telomerase reverse transcriptase regulates telomere repeat addition rate and processivity. Nucleic Acids Res., 38, 1982-1996.
32. D'Souza, Y., Chu, T.W. and Autexier, C. (2013) A translocationdefective telomerase with low levels of activity and processivity stabilizes short telomeres and confers immortalization. Mol. Biol. Cell., 24, 1469-1479.
33. Tsakiri, K.D., Cronkhite, J.T., Kuan, P.J., Xing, C., Raghu, G., Weissler, J.C., Rosenblatt, R.L., Shay, J.W. and Garcia, C.K. (2007) Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl Acad. Sci. USA, 104, 7552-7557.
34. Robart, A.R. and Collins, K. (2010) Investigation of human telomerase holoenzyme assembly, activity, and processivity using disease-linked subunit variants. J. Biol. Chem., 285, 4375-4386.
35. Armanios, M.Y., Chen, J.J., Cogan, J.D., Alder, J.K., Ingersoll, R.G., Markin, C., Lawson, W.E., Xie, M., Vulto, I., Phillips, J.A. 3rd et al. (2007) Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med., 356, 1317-1326.
36. Du, H.Y., Pumbo, E., Ivanovich, J., An, P., Maziarz, R.T., Reiss, U.M., Chirnomas, D., Shimamura, A., Vlachos, A., Lipton, J.M. et al. (2009) TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood, 113, 309-316.
37. Xin, Z.T., Beauchamp, A.D., Calado, R.T., Bradford, J.W., Regal, J.A., Shenoy, A., Liang, Y., Lansdorp, P.M., Young, N.S. and Ly, H. (2007) Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood, 109, 524-532.
38. Du, H.Y., Pumbo, E., Manley, P., Field, J.J., Bayliss, S.J., Wilson, D.B., Mason, P.J. and Bessler, M. (2008) Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. Blood, 111, 1128-1130.
39. Hahn, W.C., Stewart, S.A., Brooks, M.W., York, S.G., Eaton, E., Kurachi, A., Beijersbergen, R.L., Knoll, J.H., Meyerson, M. and Weinberg, R.A. (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat. Med., 5, 1164-1170.
40. Fu, D. and Collins, K. (2003) Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs. Mol. Cell., 11, 1361-1372.
41. Bryan, T.M., Marusic, L., Bacchetti, S., Namba, M. and Reddel, R.R. (1997) The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet., 6, 921-926.
42. Zhong, F.L., Batista, L.F., Freund, A., Pech, M.F., Venteicher, A.S. and Artandi, S.E. (2012) TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell, 150, 481-494.
43. Armanios, M. and Blackburn, E.H. (2012) The telomere syndromes. Nat. Rev. Genet., 13, 693-704.
44. Banik, S.S., Guo, C., Smith, A.C., Margolis, S.S., Richardson, D.A., Tirado, C.A. and Counter, C.M. (2002) C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity. Mol. Cell. Biol., 22, 6234-6246.
45. Xu, D., Dwyer, J., Li, H., Duan, W. and Liu, J.P. (2008) Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. J. Biol. Chem., 283, 23567-23580.
46. Alder, J.K., Cogan, J.D., Brown, A.F., Anderson, C.J., Lawson, W.E., Lansdorp, P.M., Phillips, J.A. III, Loyd, J.E., Chen, J.J. and Armanios, M. (2011) Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis. PLoS Genet., 7, e1001352.
47. Marrone, A., Walne, A., Tamary, H., Masunari, Y., Kirwan, M., Beswick, R., Vulliamy, T. and Dokal, I. (2007) Telomerase reversetranscriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood, 110, 4198-4205.
48. Errington, T.M., Fu, D., Wong, J.M. and Collins, K. (2008) Diseaseassociated human telomerase RNA variants show loss of function for telomere synthesis without dominant-negative interference. Mol. Cell. Biol., 28, 6510-6520.
49. Sauerwald, A., Sandin, S., Cristofari, G., Scheres, S.H., Lingner, J. and Rhodes, D. (2013) Structure of active dimeric human telomerase. Nat. Struct. Mol. Biol., 20, 454-460.
50. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server for predicting damaging missense mutations. Nat. Methods, 7, 248-249.
51. Mitchell, M., Gillis, A., Futahashi, M., Fujiwara, H. and Skordalakes, E. (2010) Structural basis for telomerase catalytic subunit TERT binding to RNA template and telomeric DNA. Nat. Struct. Mol. Biol., 17, 513-518.